Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
International Immunopharmacology|August 31, 2024
Efficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinomaNaicheng Song, Zhaokai Wang, Quanchao Sun, et al.
Translational Lung Cancer Research|September 15, 2025
Preoperative diagnostic accuracy of dominant lesion in multifocal pulmonary nodulesBowen Zhao, Xiaoyun Su, Yu Huang, et al.
BMC Cancer|November 1, 2023
Immune characteristics analysis and construction of a four-gene prognostic signature for lung adenocarcinoma based on estrogen reactivityYangwei Wang, Tong Yu, Jiaping Chen, et al.
Translational Lung Cancer Research|July 14, 2022
Feasibility and safety of pedicled autologous bronchial flap reconstruction airway instead of sleeve lobectomy in partial lung cancer surgeryZheng Zhang, Xiaonu Peng, Bo Ai, et al.
Oncology Reports|May 5, 2020
Estrogen promotes the metastasis of non‑small cell lung cancer via estrogen receptor β by upregulation of Toll‑like receptor 4 and activation of the myd88/NF‑κB/MMP2 pathwaySheng Fan, Yongde Liao, Wenlin Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2026
PET/CT-Guided Neoadjuvant Tislelizumab Plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final AnalysisYushang Yang, Xiaolong Yan, Hongjing Jiang, et al.
International Journal of Surgery (London, England)|July 3, 2025
Multichannel deep learning prediction of major pathological response after neoadjuvant immunochemotherapy in lung cancer: a multicenter diagnostic studyZuhan Geng, Kuo Li, Peiyuan Mei, et al.
Journal for Immunotherapy of Cancer|September 4, 2024
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter studyGuanchao Ye, Guangyao Wu, Yu Qi, et al.
Translational Lung Cancer Research|April 15, 2026
Prognostic implications of dominant lesion misidentification in multiple primary lung cancerBowen Zhao, Xiaoyun Su, Yu Huang, et al.
BMC Medical Imaging|December 3, 2024
CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter studyYuting Zheng, Peiyuan Mei, Mingliang Wang, et al.
Pageof 8